Evidence map›Paper›PMID 30373535›Full record

ArticleBMC infectious diseases2018

Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison.

Komal Chacowry Pala, Stéphanie Baggio, Nguyen Toan Tran, François Girardin, Hans Wolff, Laurent Gétaz

Abstract read
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. HCV disease burden and population segments in Switzerland.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Komal Chacowry PalaDivision of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland.
Stéphanie BaggioDivision of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland. stephanie.baggio@hcuge.ch.
Nguyen Toan TranDivision of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland.
François GirardinMedical Direction and Division of Clinical Pharmacology, Toxicology Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
Hans WolffDivision of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland.
Laurent GétazDivision of Prison Health, Geneva University Hospitals, University of Geneva, Chemin de Champ-Dollon 22, 1241 Puplinge, Geneva, Switzerland.

Funding

Federal Office of Public Health 09.003678
6 · The paper itself

Abstract

backgroundIncarcerated people carry a high burden of infection, including blood-borne diseases (BBDs). It is also known that one million people contract a sexually transmitted infection (STI) every day worldwide, which represents a global public health challenge. However, data regarding the prevalence of STIs and the risk factors among incarcerated populations are lacking. The objective of this study was to determine the prevalence and associated factors of BBDs and STIs among detainees in the largest pre-trial prison in Switzerland.

methodsIn a cross-sectional study conducted at the Champ-Dollon pre-trial prison, 273 male detainees answered a standardized questionnaire and were screened for syphilis, herpes simplex virus 2 (HSV-2), HIV, and hepatitis C (HCV). Prevalence rates and associations of BBDs and STIs with risk factors were computed.

resultsMost participants (90.9%) were migrants from outside Western Europe, and 5.9% were injecting drug users. HCV was diagnosed among 6.2% of participants (antibody prevalence). The prevalence of HCV was higher among injecting drug users (81.2%) than non-injectors (1.6%). The prevalence of HIV, syphilis, and HSV-2 was 0.4%, 1.1%, and 22.4%, respectively. HCV was associated with a history of injecting drug use and HSV-2 with a lower education level and being older than 26 years.

conclusionsThis study showed the infection prevalence of 2-9 times higher among detainees than in the Swiss community. It also illustrated that these infections are associated with sociodemographic and risk factors. Therefore, the prison environment offers an opportunity to strengthen infectious disease control programs targeting specific subgroups of at-risk people. Such programs would benefit both the prison population and broader society.

Indexed as

AdolescentAdultCross-Sectional StudiesHepatitis CHerpes GenitalisHIV InfectionsHumansMaleMiddle AgedOdds RatioPrevalencePrisonersRisk FactorsSexually Transmitted DiseasesSubstance-Related DisordersSurveys and QuestionnairesEpidemiologyHepatitis CHerpesvirus 2, humanHIVPrisonSyphilis

Identifiers

PMID30373535
PMCPMC6206665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.